Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: A population-based study

A. Rittig (Aarhus, Denmark), O. Hilberg (Vejle, Denmark), A. Løkke (Aarhus, Denmark)

Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session: CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session type: Poster Discussion
Number: 3659
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Rittig (Aarhus, Denmark), O. Hilberg (Vejle, Denmark), A. Løkke (Aarhus, Denmark). Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: A population-based study. 3659

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study
Source: ERJ Open Res, 5 (4) 00259-2018; 10.1183/23120541.00259-2018
Year: 2019



Mortality risk prediction with ILD-GAP index in a portuguese chronic hypersensitivity pneumonitis cohort
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020
Year: 2020



The association of comorbidity clusters with long-term survival and incidence of exacerbation in a COPD cohort. The HUNT Study, Norway.
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


A cohort study of allergic sensitization among adults – Incidence, remission, risk factors and age-effect on prevalence
Source: Annual Congress 2010 - New insights in the epidemiology of asthma
Year: 2010

Squeaks in hypersensitivity pneumonitis: prevalence and clinical correlates
Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin
Year: 2019



COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020


Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study
Source: ERJ Open Res, 5 (1) 00014-2019; 10.1183/23120541.00014-2019
Year: 2019



Risk factors for respiratory failure in patients with COVID-19 pneumonitis: A retrospective study
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021


Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study
Source: Eur Respir J, 54 (5) 1900804; 10.1183/13993003.00804-2019
Year: 2019



Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study
Source: Eur Respir J, 56 (3) 2000767; 10.1183/13993003.00767-2020
Year: 2020



Incidence, prevalence and mortality of rheumatoid arthritis-associated interstitial lung disease : a retrospective study
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021


Mortality in bronchiectasis: a long-term study assessing the factors influencing survival
Source: Eur Respir J 2009; 34: 843-849
Year: 2009



Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam Study
Source: ERJ Open Res, 6 (2) 00300-2019; 10.1183/23120541.00300-2019
Year: 2020



Late Breaking Abstract - Inhaled corticosteroids in bronchiectasis is associated to increased morbidity, Pseudomonas colonization and mortality – a five-year prospective cohort study
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020


Employment, treatment and lung function outcomes at 1-year following diagnosis of occupational hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Year: 2020


Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study
Source: Eur Respir J, 57 (4) 2004055; 10.1183/13993003.04055-2020
Year: 2021



Multinational, database cohort study to study mortality and risk factors of mortality in patients with asthma
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016


Incidence and risk factors of frequent asthma exacerbations in a multinational, multidatabase cohort study
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019


Incidence and persistence of specific immunological sensitization: long-term follow-up of a cohort of apprentices
Source: Eur Respir J 2005; 26: Suppl. 49, 34s
Year: 2005